A CD1d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivity. [electronic resource]
Producer: 20100326Description: 2107-15 p. digitalISSN:- 1550-6606
- Allergens -- administration & dosage
- Animals
- Antigens, CD1d -- metabolism
- Binding, Competitive -- immunology
- Bronchial Hyperreactivity -- immunology
- Cell Line
- Disease Models, Animal
- Female
- Galactosylceramides -- administration & dosage
- Humans
- Immunosuppressive Agents -- antagonists & inhibitors
- Lymphocyte Activation -- drug effects
- Mice
- Mice, Inbred BALB C
- Natural Killer T-Cells -- immunology
- Ovalbumin -- administration & dosage
- Phosphatidylethanolamines -- administration & dosage
- Polyethylene Glycols -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.